Jordan Axelrad

Assistant Professor

NYU Langone Health

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jordan Axelrad is an Assistant Professor at NYU Langone Health in the United States. His research primarily focuses on inflammatory bowel disease, with recent articles addressing clinical outcomes, disparities in treatment, and risk factors associated with the condition. His work includes examining malnutrition risks, the efficacy of treatment regimens, and the impact of enteric infections on patient outcomes.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Thomas Greuter

SWITZERLAND

Jordan Axelrad

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City

Editorial: Resecting Assumptions—Do Proctocolectomy Guidelines Hold Up?

Risk of malnutrition increases in the year prior to surgery among patients with inflammatory bowel disease

Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease

PCR-based stool testing for enteric infections in flares of inflammatory bowel disease: Is more data worth the cost?

GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD

Inflammatory Bowel Disease, Periconceptional Disease Activity, and Risk of Major Congenital Anomalies: A Nationwide Cohort Study

A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk

Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years

Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection

Atherosclerosis as a Risk Factor for IBD: A Population-Based Case-Control Study

Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden

ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn’s Disease Following Ileocecal Resection

Pathogen-Specific Alterations in the Gut Microbiota Predict Outcomes in Flare of Inflammatory Bowel Disease Complicated by Gastrointestinal Infection

Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis

Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease

The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death.

Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia

A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial

Collaborators (19)

Thomas Greuter

Jonas Halfvarson

Tim Raine

Jan Marsal

Johan Burisch

Raymond Cross

William Schreiber-Stainthorp

Ola Olén

Daniel Mucida

Robert Sandler

Yu Matsuzawa

Bernardo Sgarbi Reis

Triana Lobaton Ortega

Jonas Ludvigsson

Maria Gabriela Noval

Martin Neovius

Victor J. Torres

Jiangwei Sun

Jonathan Klein

Make your next move.